Activation of neurohumoral systems in postinfarction left ventricular dysfunction.
about
New competition in the realm of renin-angiotensin axis inhibition; the angiotensin II receptor antagonists in congestive heart failure.Functional networks of nucleocytoplasmic transport-related genes differentiate ischemic and dilated cardiomyopathies. A new therapeutic opportunityDyslipidemia, low left ventricular ejection fraction and high wall motion score index are predictors of progressive left ventricular dilatation after acute myocardial infarctionAngiotensin II receptor blockers in heart failure.beta blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study.NT-proBNP in heart failure: therapy decisions and monitoring.AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment.Progressive dilation of the left atrium and ventricle after acute myocardial infarction is associated with high mortality.Percutaneous Ventricular Restoration with a Partitioning Device for Ischemic Heart Failure Treatment.Differential effects of antihypertensive drugs on neurohormonal activation: insights from a population-based sample.Heart rate variability in patients hospitalized for decompensated diastolic heart failure at admission and after clinical stabilization.Neuroendocrine activation after myocardial infarction: causes and consequences.Is neurohormonal activation a major determinant of the response to ACE inhibition in left ventricular dysfunction and heart failure?Responses to low dose intravenous perindoprilat infusion in salt deplete/salt replete normotensive volunteers.Neuroendocrine activation after myocardial infarctionAn open-label study of nefazodone treatment of major depression in patients with congestive heart failure.The role of the neurohormonal system in heart failure.NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy.Sympathetic activation in congestive heart failure: reproducibility of neuroadrenergic markers.Identification of a Common Different Gene Expression Signature in Ischemic Cardiomyopathy.Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker.Disruption of the relationship between renin and atrial natriuretic peptide early in the course of ventricular dysfunction.Augmentation of autophagy by atorvastatin via Akt/mTOR pathway in spontaneously hypertensive rats.QT dispersion as a predictor of long-term mortality in patients with acute myocardial infarction and clinical evidence of heart failureChanges in autonomic balance in patients with decompensated chronic heart failure
P2860
Q31989723-F324CB04-B77E-42D9-A385-A530D6470225Q34066250-B2C32D18-5DCA-49B1-9151-55D79A8A05A2Q34811430-B172A9AF-C3E6-4697-B653-E6F1B815D2CDQ35066800-56FDBECC-4FEE-4EDC-B2D3-4BECB48C5197Q35370417-DA0D111F-B472-4882-B0C6-A177AA6ADD5EQ35677310-7BABACFD-5B75-413C-9810-644EA9C65B32Q35925706-4013D4CA-AAB0-43FA-A0E0-D9F1EE8A8054Q36835952-1089ECD9-866D-4341-AD3E-66F19D2CA727Q37399617-F240AE7B-9C51-464A-9DD8-0965A7891C66Q38942973-F68DABE9-EEC6-4DEB-948A-D6D6C2A9D0FAQ39490174-C1B76AC9-0E3C-4875-91CA-C11BB3B384DAQ39611871-3D3C14B5-6C64-4470-A91B-1FB71FCEDB83Q41284840-E1B62C1A-D280-45E8-9CD1-F11EA65EFDFAQ42180567-5F1080AD-FBBE-4C46-BDD8-C7747D4F3995Q42221989-77844730-BAAD-40EE-B079-90C4AA6E44C2Q42578761-E483745A-03F4-430B-B473-8402974B55A6Q42615490-018920CB-D9BA-4859-BD86-34644FADFA3EQ43018678-2FAD77F2-22DF-497E-9C11-3800B3CAF5ABQ44778772-07E40E0E-1890-45B0-893C-22BB2EB5ADC7Q45106861-35268767-1151-425F-B55B-15BE359B2E82Q48182328-E9331135-4429-4886-B970-2F5E29E2D780Q48358493-05758001-52D9-4CE4-B98E-048390EE818AQ52540393-126A810E-F7C9-44F8-84A8-5B9427D98396Q54255955-84AF6406-27A3-4808-8F7D-6CB14DDFD9BDQ56458918-E250DC81-CBD4-4435-8B04-586891F76312Q57911468-EE2CE138-DC0A-434D-B75C-076E9D7F17D6
P2860
Activation of neurohumoral systems in postinfarction left ventricular dysfunction.
description
1993 nî lūn-bûn
@nan
1993 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Activation of neurohumoral systems in postinfarction left ventricular dysfunction.
@ast
Activation of neurohumoral systems in postinfarction left ventricular dysfunction.
@en
Activation of neurohumoral systems in postinfarction left ventricular dysfunction.
@nl
type
label
Activation of neurohumoral systems in postinfarction left ventricular dysfunction.
@ast
Activation of neurohumoral systems in postinfarction left ventricular dysfunction.
@en
Activation of neurohumoral systems in postinfarction left ventricular dysfunction.
@nl
prefLabel
Activation of neurohumoral systems in postinfarction left ventricular dysfunction.
@ast
Activation of neurohumoral systems in postinfarction left ventricular dysfunction.
@en
Activation of neurohumoral systems in postinfarction left ventricular dysfunction.
@nl
P2093
P1476
Activation of neurohumoral systems in postinfarction left ventricular dysfunction
@en
P2093
G R Dagenais
J L Rouleau
J M Arnold
J de Champlain
P304
P356
10.1016/0735-1097(93)90042-Y
P407
P577
1993-08-01T00:00:00Z